CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Net sales	$ 129,313	$ 128,209	$ 245,113	$ 263,352
Cost of sales	(88,766)	(90,446)	(174,375)	(183,171)
Gross profit	40,547	37,763	70,738	80,181
Operating expenses
Selling, general and administrative	(28,757)	(31,051)	(55,385)	(60,520)
Research, product development and regulatory	(5,803)	(8,599)	(11,485)	(14,305)
Transformation	(1,621)	(7,345)	(3,812)	(8,497)
Operating income (loss)	4,366	(9,232)	56	(3,141)
Change in fair value of equity investments	0	(125)	0	513
Interest expense, net	(4,450)	(3,917)	(8,215)	(7,610)
Loss before provision for income taxes	(84)	(13,274)	(8,159)	(10,238)
Income tax (expense) benefit	(765)	1,553	(1,152)	69
Net loss	$ (849)	$ (11,721)	$ (9,311)	$ (10,169)
Net loss per common share-basic	$ (0.03)	$ (0.42)	$ (0.33)	$ (0.36)
Net loss per common share-assuming dilution	$ (0.03)	$ (0.42)	$ (0.33)	$ (0.36)
Weighted average shares outstanding-basic	28,345	28,024	28,308	27,934
Weighted average shares outstanding-assuming dilution	28,345	28,024	28,308	27,934